List view / Grid view
15 July 2011 | By Janssen Pharmaceuticals Inc
Janssen Pharmaceuticals, Inc. announced a definitive agreement to divest the assets of its Ortho Dermatologics division...
15 July 2011 | By Roche
Roche plans to seek approval with Health Authorities based on encouraging results...
14 July 2011 | By ICON plc
ICON plc, announced the acquisition of Firecrest Clinical, a market-leading provider of technology solutions that boost investigator site performance and study management...
14 July 2011 | By Cephalon Inc.
Cephalon, Inc. announced that its stockholders voted to approve the TEVA proposal to acquire Cephalon...
14 July 2011 | By Novo Nordisk
Novo Nordisk has been granted approval by the European Commission for the new prefilled insulin pen – FlexTouch®...
14 July 2011 | By Bristol-Myers Squibb
The European Commission has approved YERVOY™ (ipilimumab)...
12 July 2011 | By Gilead Sciences
Gilead Sciences, Inc. announced an expansion of its global access program...
12 July 2011 | By Sanofi
Sanofi and Regeneron Pharmaceuticals, Inc. announced results from Phase 2b trials...
11 July 2011 | By Citigate Dewe Rogerson
Clavis Pharma ASA, is pleased to announce the appointment of Nicholas Adams as Chief Business Officer...
11 July 2011 | By Eli Lilly and Company
Biopharmaceuticals be included in transatlantic trade and economic discussions...
11 July 2011 | By Sanofi
Sanofi and Genzyme announced positive top-line results...
11 July 2011 | By Sanofi
Sanofi announced the strategic divestiture of its dermatology business, Dermik, to Valeant Pharmaceuticals International Inc...
8 July 2011 | By Novartis
Novartis announced Phase III trial results...
7 July 2011 | By Sanofi
Sanofi announced that the company has discontinued the PALLAS Phase IIIb trial...
7 July 2011 | By Citigate Dewe Rogerson
Pharminox has completed a new round of equity funding, raising approximately £1.5m...
